Wednesday, February 24, 2021
ATHE as of 02/24/2021
MARKET CRASH STUDY => OPEN AT 1.61 AND LOWEST AT 1.58 AS OF TODAY MARCH 10 2021
| ID | STOCK | DATE | TIME | CURRENT-$ | AVG MONEY | AMOUNT | TOTAL EQUITY | Field4 | MARKET PRICE | CURRENT PRICE | AMT(NT) | NL | FILL PRICES | FILLED AMOUNT | FILLED TOTAL | Field2 | TOTAL SHARE | Field3 | AVG | REMARK NET LOSS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 235 | ATHE | 3/3/2021 | 8:58:00 AM | $1.81 | 200 | $362.00 | $1.61 | ($0.20) | 200 | ($40.00) | $1.61 | 200 | $322.00 | $684.00 | 400 | $684.00 | $1.71 |
Subscribe to:
Posts (Atom)
ANGI
share 12.01 market 2.25 AVG 2.32 (2.95 ) % down today 0.88% purchase date 04 April 2024 2.34 3 April 2024 2.48 4 April 2024 2.30
-
ST ID stock number price TOTAL PRICE plan current price NUMBER OF SHARE current lost price net loss fill amount filled... -
Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) tumbled 63.9% to close at $0.4555 on Monday after the company received a #Refusal to Fil... -
Yeh Updating the market on its flagship immunotherapeutic agent pelareorep, Oncolytics Biotech Inc. (NASDAQ: ONCY ) (TSX:ONC) laid out its...
